Need help staying current on recent changes in clinical practice guidelines? This session is for you! These 15-minute practical presentations will provide a practical review of recent updates in clinical practice guidelines for inflammatory bowel disease, deprescribing, HIV pre-exposure prophylaxis, and medication assisted therapy for opioid use disorders. Listen to a quick summary of what’s changed and how to apply these changes to patients in your practice.
Upon successful completion of this application-based CPE activity, pharmacists should be able to:
1. Describe current guideline recommendations concerning therapeutic drug monitoring of anti-TNF agents in inflammatory bowel disease.
2. Discuss differences in recommendations between proactive versus reactive therapeutic drug monitoring in inflammatory bowel disease.
3. Describe the need for addressing polypharmacy.
4. Apply the steps from the protocol "Reducing Inappropriate Polypharmacy: The Process of Deprescribing" to patients in your practice.
5. Apply the key recommendations of the latest DHHS HIV Treatment Guidelines to patients in your practice.
6. Apply the key recommendations and patient education points for medication-assisted therapy (MAT) in the 2018 Medications for Opioid Use Disorder Treatment Improvement Protocol (TIP) 63 to patients in your community pharmacy practice.
*CEI provides you with two (2) opportunities to complete the exam. If there are two failed attempts, the participant will not receive CPE credit.
Financial Support: There was no financial support provided for this activity.
Activity Fee: An activity fee of $10.00 will be assessed for grading the exam instrument and issuing the CE Statement of Credit.